EQS-NVR: Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


EQS Total Voting Rights Announcement: Epigenomics AG / Total Voting Rights Announcement
Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

22.11.2023 / 11:09 CET/CEST
Total Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Werbung


Publication of total number of voting rights

1. Details of issuer
Epigenomics AG
Bertha-Benz-Straße 5
10557 Berlin
Germany

2. Type of capital measure
  Type of capital measure Date of status / date of effect
  Conditional capital increase (Sec. 41 para. 2 WpHG)
X Other capital measure (Sec. 41 para. 1 WpHG) 22 Nov 2023

3. New total number of voting rights:
853417



22.11.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Epigenomics AG
Bertha-Benz-Straße 5
10557 Berlin
Germany
Internet: www.epigenomics.com

 
End of News EQS News Service

Werbung

1779537  22.11.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1779537&application_name=news&site_id=smarthouse
Werbung

Epigenomics Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Epigenomics nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"

Keine Analysen gefunden.